Valuation: Sartorius Stedim Biotech

Market Cap 15.96B 18.14B 14.82B 13.63B 25.57B 1,757B 26.03B 177B 69.14B 857B 68.11B 66.64B 2,973B P/E 2026 *
42.9x
P/E 2027 * 32.4x
Enterprise Value 17.97B 20.43B 16.69B 15.35B 28.79B 1,978B 29.31B 200B 77.85B 965B 76.69B 75.04B 3,348B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.09x
Free-Float
28.47%
Yield 2026 *
0.5%
Yield 2027 * 0.63%
1 day+2.80%
1 week-9.21%
Current month-7.16%
1 month-0.35%
3 months+3.88%
6 months-19.25%
Current year-19.71%
1 week 158.9
Extreme 158.9
187.4
1 month 158.9
Extreme 158.9
190.8
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
287.8
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
+2.87%-9.21%-3.79%-38.22% 18.14B
+0.18%+1.94%-19.93%-11.85% 175B
+0.15%-1.85%-10.87%-7.81% 105B
+1.49%-0.95%+3.96%+58.40% 59.35B
-1.13%-2.60%+26.37%+54.76% 50.71B
-0.12%-4.35%-16.22%-42.24% 42.15B
+1.21%-8.47% - - 31.82B
-1.33%-9.62%-18.45%-46.03% 27.2B
-0.82%-1.92%+56.39%-5.79% 25.11B
+0.03%-4.74%-6.58%-9.24% 20.53B
Average +0.29%-4.33%+1.21%-5.34% 55.55B
Weighted average by Cap. +0.28%-1.87%-5.80%-1.37%

Financials

2026 *2027 *
Net sales 3.13B 3.56B 2.91B 2.67B 5.02B 345B 5.11B 34.78B 13.57B 168B 13.36B 13.07B 583B 3.48B 3.96B 3.23B 2.97B 5.58B 383B 5.68B 38.67B 15.08B 187B 14.86B 14.54B 649B
Net income 369M 420M 343M 316M 592M 40.67B 602M 4.1B 1.6B 19.84B 1.58B 1.54B 68.81B 482M 548M 448M 412M 772M 53.07B 786M 5.35B 2.09B 25.88B 2.06B 2.01B 89.8B
Net Debt 2.01B 2.29B 1.87B 1.72B 3.22B 221B 3.28B 22.33B 8.71B 108B 8.58B 8.4B 375B 1.77B 2.01B 1.64B 1.51B 2.83B 195B 2.88B 19.63B 7.66B 94.91B 7.54B 7.38B 329B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,477
Date Price Change Volume
26-07-24 168.70 +2.87% 34,524
26-07-23 €164.00 -6.45% 215,014
26-07-22 €175.30 +5.22% 134,439
26-07-21 €166.60 -7.55% 213,161
26-07-20 €180.20 -2.96% 55,079
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
164.00EUR
Average target price
231.57EUR
Spread / Average Target
+41.20%

Quarterly revenue - Rate of surprise